Divi's Laboratories Limited
NSE: DIVISLAB · Healthcare
₹8,744.50
+248.50 (+2.92%)
Last close · 30 Aug 2026, 2:51 am IST
- Open
- ₹8,500.00
- Day high
- ₹8,744.50
- Day low
- ₹8,497.00
- Volume
- 5.64 L
- Prev close
- ₹8,496.00
HealthcareDrug Manufacturers - Specialty & GenericPart of:All NSE StocksNifty 100Nifty 200Nifty 500Nifty HealthcareNifty Next 50Nifty Pharma
Price chart
Range
EMA
Also show
Fundamentals
Drug Manufacturers - Specialty & Generic
Valuation
- Market Cap
- 1,92,425 Cr
- Price
- 7,248.50
- P/E (TTM)
- 75.18
- P/E (Fwd)
- 51.49
- P/B
- 11.48
- EV/EBITDA
- 55.03
- EV/Revenue
- 17.92
- PEG
- —
- Div Yield
- 0.41%
- 52W High
- 7,438.50
- 52W Low
- 5,636.50
- Beta
- 0.22
Profitability & income
- Revenue (TTM)
- 10,560 Cr
- Net Income (TTM)
- 2,568 Cr
- EBITDA
- 3,438 Cr
- Gross Margin
- 59.06%
- Op. Margin
- 28.75%
- Net Margin
- 24.32%
- ROE
- 16.19%
- ROA
- 10.07%
- EPS (TTM)
- 96.41
- EPS (Fwd)
- 140.78
Financial health
- Total Debt
- 7 Cr
- Total Cash
- 3,233 Cr
- Debt/Equity
- 0.04
- Current Ratio
- 5.43
- Quick Ratio
- 3.27
- Book Value
- 631.37
- Free Cash Flow
- -928 Cr
- Op. Cash Flow
- 2,738 Cr
Growth
- Revenue Growth
- 9.50%
- Earnings Growth
- 13.60%
- Earnings QoQ
- 13.40%
Quarterly results
| Period | Revenue | Net Income | EBITDA | Op. Income | Gross Profit | Op. Cash Flow | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 2,831 Cr | 751 Cr | 1,089 Cr | 814 Cr | 1,712 Cr | — | 7 Cr | 16,761 Cr |
| 2025-12-31 | 2,604 Cr | 583 Cr | 904 Cr | 772 Cr | 1,659 Cr | — | — | — |
| 2025-06-30 | 2,410 Cr | 545 Cr | 848 Cr | 617 Cr | 1,454 Cr | — | — | — |
| 2025-03-31 | 2,585 Cr | 662 Cr | 972 Cr | 779 Cr | 1,604 Cr | — | 4 Cr | 14,969 Cr |
| 2024-12-31 | 2,319 Cr | 589 Cr | 825 Cr | 644 Cr | 1,397 Cr | — | — | — |
Annual results
| Period | Revenue | Net Income | EBITDA | Op. Income | Gross Profit | Op. Cash Flow | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 10,476 Cr | 2,568 Cr | 3,874 Cr | 2,979 Cr | 6,195 Cr | 2,738 Cr | 7 Cr | 16,761 Cr |
| 2025-03-31 | 9,325 Cr | 2,191 Cr | 3,320 Cr | 2,571 Cr | 5,455 Cr | 1,653 Cr | 4 Cr | 14,969 Cr |
| 2024-03-31 | 7,796 Cr | 1,600 Cr | 2,544 Cr | 1,832 Cr | 4,527 Cr | 1,261 Cr | 3 Cr | 13,571 Cr |
| 2023-03-31 | 7,665 Cr | 1,824 Cr | 2,712 Cr | 2,027 Cr | 4,487 Cr | 2,459 Cr | 4 Cr | 12,767 Cr |
| 2022-03-31 | — | — | — | — | — | — | — | — |
Figures in ₹ crore unless stated. Ratios and margins are trailing twelve months where marked TTM.
Want charts and signals for DIVISLAB?
Sign in for candlestick charts with Supertrend, MACD and VWAP overlays, plus watchlists and email alerts.
Sign in